# Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

> **NCT07145437** · NA · NOT_YET_RECRUITING · sponsor: **Clinique Sainte Clotilde** · enrollment: 220 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Radio-induced Lymphocyte Apoptosis (RILA) Assay
- **RADIATION:** Stereotactic body radiotherapy (SBRT)

## Key facts

- **NCT ID:** NCT07145437
- **Lead sponsor:** Clinique Sainte Clotilde
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2030-11-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145437, "Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07145437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*